Diflubenzuron
3 Inquiries
35367-38-5
Technical
99%
Any China Port
1kg/as customer's requirment
2020-05-21
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Diflubenzuron
Other Name:Benzamide,N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluoro-;N-[[(4-Chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide;PH 60-40;OMS 1804;TH 6040;1-(4-Chlorophenyl)-3-(2,6-difluorobenzoyl)urea;Thompson-Hayward 6040;Difluron;Dimilin;Diflubenzuron;Duphar PH 60-40;AI 3-29054;N-(2,6-Difluorobenzoyl)-N′-(4-chlorophenyl)urea;Larvakil;Dimilin 25;N-(p-Chlorophenyl)-N′-(2,6-difluorobenzoyl)urea;Micromite;Micromite (Uniroyal);Minerin;Suniao-one;Rotadin;Du-Dim;Sniper;Sniper (benzoylurea insecticide);Mosdop P;Mosdop TB;104790-81-0;51026-04-1;53026-03-2;66594-18-1
CAS No.:35367-38-5
Molecular Formula:C14H9ClF2N2O2
InChIKeys:InChIKey=QQQYTWIFVNKMRW-UHFFFAOYSA-N
Molecular Weight:310.68
Exact Mass:310.68
EC Number:252-529-3
UNII:J76U6ZSI8D
UN Number:3077|2588
DSSTox ID:DTXSID1024049
Color/Form:Colorless crystals
HScode:2924299031
Categories:
Characteristics-
PSA:
58.2
XLogP3:3.88
Appearance:Solid
Density:1.57 at 20 deg C
Melting Point:239 °C
Boiling Point:BP: 257 °C at 300 mm Hg
Water Solubility:H2O: 0.008 g/100 mL;Almost insoluble in apolar solvents. Moderate to good solubility in most polar-to-very polar solvents.
Storage Conditions:0-6°C
Vapor Pressure:1.2 x l0 -4 mPa (25 °C)
Toxicity:LD50 in mice, rats (formulation with 50% kaolin) (g/kg): 4.64, >10 orally (Mulder, Gijswijt)
Henrys Law Constant:Henry's Law constant = 4.6X10-9 atm-cu m/mol at 25 °C (est)
Collision Cross Section:160.98 Ų [M+H]+ [CCS Type: TW]|161.73 Ų [M+H]+
Experimental Properties:Decomposes on distillation|In aqueous solution (20 °C), stable at pH 5 and pH 7 (half-life > 180 days); at pH 9, half-life of 32.5 days|Hydroxyl radical reaction rate constant = 1.6X10-11 cu cm/molec-sec at 25 °C (est)
Air and Water Reactions:Hydrolyzed in alkaline solution above pH 9.0.
Reactive Group:Amides and Imides
Reactivity Profile:A urea derivative.
Corrosivity:Non-corrosive
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Dermal
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H312 Harmful in contact with skin
H400 Very toxic to aquatic life
Precautionary statement(s) Prevention P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P273 Avoid release to the environment.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P317 Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P391 Collect spillage.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store in a dry location.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
Chile
Diflubenzuron
1 KG Apr 23, 2026 
Mexico
Diflubenzuron
25 KG May 28, 2025 
India
Diflubenzuron Technical
1.00 TON May 21, 2024 Post an enquiry for this product
